4//SEC Filing
Fairmount Healthcare Fund II L.P. 4
Accession 0001104659-25-119320
CIK 0001253689other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:30 PM ET
Size
13.2 KB
Accession
0001104659-25-119320
Insider Transaction Report
Form 4
Fairmount Funds Management LLC
Director10% Owner
Transactions
- Purchase
Ordinary Shares
2025-12-04$13.41/sh+1,360,000$18,237,600→ 2,747,866 total(indirect: By Fairmount Healthcare Fund II L.P.) - Purchase
Pre-Funded Warrant (Right to Buy)
2025-12-04$13.41/sh+131,434$1,762,399→ 1,768,140 total(indirect: By Fairmount Healthcare Fund II L.P.)Exercise: $0.00→ Ordinary Shares (131,434 underlying)
Fairmount Healthcare Fund II L.P.
Director10% Owner
Transactions
- Purchase
Ordinary Shares
2025-12-04$13.41/sh+1,360,000$18,237,600→ 2,747,866 total(indirect: By Fairmount Healthcare Fund II L.P.) - Purchase
Pre-Funded Warrant (Right to Buy)
2025-12-04$13.41/sh+131,434$1,762,399→ 1,768,140 total(indirect: By Fairmount Healthcare Fund II L.P.)Exercise: $0.00→ Ordinary Shares (131,434 underlying)
Kiselak Tomas
Director10% Owner
Transactions
- Purchase
Ordinary Shares
2025-12-04$13.41/sh+1,360,000$18,237,600→ 2,747,866 total(indirect: By Fairmount Healthcare Fund II L.P.) - Purchase
Pre-Funded Warrant (Right to Buy)
2025-12-04$13.41/sh+131,434$1,762,399→ 1,768,140 total(indirect: By Fairmount Healthcare Fund II L.P.)Exercise: $0.00→ Ordinary Shares (131,434 underlying)
Harwin Peter Evan
Director10% Owner
Transactions
- Purchase
Ordinary Shares
2025-12-04$13.41/sh+1,360,000$18,237,600→ 2,747,866 total(indirect: By Fairmount Healthcare Fund II L.P.) - Purchase
Pre-Funded Warrant (Right to Buy)
2025-12-04$13.41/sh+131,434$1,762,399→ 1,768,140 total(indirect: By Fairmount Healthcare Fund II L.P.)Exercise: $0.00→ Ordinary Shares (131,434 underlying)
Footnotes (2)
- [F1]Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
- [F2]The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of outstanding shares of common stock of the Issuer immediately after giving effect to such exercise.
Documents
Issuer
CRESCENT BIOPHARMA, INC.
CIK 0001253689
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001769651
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:30 PM ET
- Size
- 13.2 KB